Our immune systems not only fight off bacteria and viruses but also keep cancerous cells in check. However, tumors can create environments that weaken immune cells, making it difficult for treatments to work. Researchers at the University of Adelaide have developed a new mRNA therapy to reprogram immune cells, specifically targeting tumor-associated macrophages that hinder T cells, which are crucial in fighting cancer. This therapy uses “smart” nanoparticles to deliver mRNA directly to the tumor site, ensuring it only affects the right cells. These nanoparticles are equipped with antibodies that bind to specific proteins on macrophages, ensuring precise targeting. The therapy also includes a drug that stimulates immune pathways, showing promising results in lab tests by activating immune cells and reducing suppressive signals. This advancement could lead to more effective cancer treatments.
QUESTION: How might advancements in targeted cancer therapies change the future of medical treatments for your generation?
‘Smart’ Nanoparticles Deliver mRNA Directly to Tumors in New Cancer Therapy
